Is it permissible to swim in the sea while in a state of impurity? What do you think?

There is so much discussion about detailed cellular effects, but are changes caused by the interaction of biofilm toxins with seawater chemistry being considered? For example, is there any data suggesting that these photo-oxidative products indirectly change pH balance or dissolved oxygen levels, creating a secondary pressure on phytoplankton? The ecosystem effect may not only be through direct harm to an individual organism.

I think when discussing the effects of biofilm toxins on phytoplankton adaptation, we must also take into account the differences among phytoplankton species. Not every phytoplankton species responds to photo-oxidative stress in the same way. Some may tolerate these toxins more easily, while others may be completely sensitive. Has a specific analysis been conducted at the species level? Or is the discussion being based on a general perception?

In addition to the differences among phytoplankton species, has it been investigated whether seasonal changes also affect this capacity for adaptation? For example, during summer, as UV exposure increases, is there a change in the toxin tolerance of phytoplankton or in their stress responses related to biofilm? If there is seasonal adaptation data, that should also be considered.

While discussing the biofilm toxins on microplastics and the adaptation of phytoplankton, one thing is missing: Are the specific molecular structures of these toxins and how biologically active they are for phytoplankton clear? Not every biofilm toxin may have the same effect; chemical differences could also influence the ability to adapt. Have the chemical profiles of biofilm-derived toxins and their effects on intracellular processes in phytoplankton been examined in detail?

The molecular structures of biofilm toxins have been discussed, but how much consideration is given to the potential reactions of these toxins with other chemical compounds in the seawater environment? Has there been any investigation into how these toxins transform through interactions with seawater salinity, dissolved inorganic carbon, or nitrogen components before becoming bioavailable to phytoplankton? In other words, there could be a missing point regarding the chemical stability of these compounds in the marine environment prior to their toxic effects.

So, what is the situation regarding the interactions of these biofilm toxins with organic matter in water? For example, is there a possibility of complexation with dissolved organic carbon (DOC)? If such binding occurs, does the bioavailability of the toxins decrease, or conversely, do they transform into a different form, potentially becoming more dangerous? Has this dynamic been studied?

Speaking of the interaction with organic matter in water, could particulate organic carbon (POC) also play a role alongside dissolved organic carbon (DOC)? Is there a study evaluating the potential of POC to contribute to sedimentation by adsorbing biofilm toxins to the surface? Such a mechanism could significantly alter the distribution of toxins in the water column and their accessibility to phytoplankton.

The relationship between biofilm toxins and POC is an important point, but a similar issue is whether these toxins accumulate in phytoplankton feeders like zooplankton. In other words, could they be creating an indirect pressure through the food chain instead of directly affecting phytoplankton adaptation? Is there any research on this?

When talking about biofilm toxins, a question came to my mind: What is the status of these toxins' effects on bacterial communities? Particularly, can indirect effects on phytoplankton be discussed via symbiotic or mutualistic relationships? Have bacterial microbiomes been taken into account in this process?

The impact of bacterial communities is significant, but we should also consider whether there could be an indirect effect of toxins through viruses. Microalgal viruses or bacteriophages that interact with phytoplankton could alter phytoplankton dynamics by exhibiting different sensitivities to toxins. Is there any research in this area?

If we are talking about the adaptive dynamics of phytoplankton, let’s take it a step further: What is the effect of these toxins on oxidative stress mechanisms? For example, is there an increase in the production of intracellular reactive oxygen species (ROS), and how does this increase affect the antioxidant defense enzymes of phytoplankton? These factors could potentially push the tolerance threshold at some point, so is there data on whether these reactions have been studied at a mechanistic level?

It is true that toxins can increase ROS production, but it is also possible that these mechanisms vary among phytoplankton species. Are there any studies measuring cellular stress through chlorophyll fluorescence? Because ROS accumulation that exceeds antioxidant defenses can directly affect photosynthesis efficiency.

Why are environmental variables so often overlooked when focusing on such specific mechanisms? For instance, how do fluctuations in water temperature influence both the chemical stability of toxins and the dynamics of ROS production? Don't interspecific differences become more complex with such parameters?

We talked about the chemical stability of toxins, but have we ever considered the possibility that this stability might vary according to the cell wall structure of phytoplankton? For instance, could there be a difference in the binding tendency of toxins between a cellulose structure and a siliceous structure? This seems like it could be a source of interspecies differences in ROS production. Shall we take a look at this?

It seems we are overlooking the effects of light intensity and the light spectrum on toxin interactions in all these discussions about the mechanisms. Could the varying wavelengths of light in the water column have an indirect effect on the chemical stability of toxins and ROS production? How do toxicity levels differ especially for phytoplankton at different depths? Is there any data on this, or is this a completely neglected area?

But why is there less discussion about the ionic composition of water regarding the solubility of toxins? I find it quite interesting whether the concentrations of calcium and magnesium affect the ROS induction mechanisms of toxins. Are there any data indicating that ionic balance changes toxin sensitivity according to phytoplankton species?

In the dynamics of toxin sensitivity, the ionic composition is accurate, but we also need to take into account the pH changes of the water. Especially, there is a possibility that acidification could modify the chemical activity of toxins through their protonation-deprotonation balance. Wouldn't such an effect elevate all these mechanisms, including ROS production, to an entirely different level?

The ionic composition and pH of water in ROS induction are being discussed, but I believe the redox potential of water should also be included in this equation. Could more reducing environments prevent toxins from remaining in their active form? Or could changes in redox potential lead to different levels of ROS production among phytoplankton species? How does this mechanism operate, especially under conditions of low oxygen solubility? Is there any data regarding this?

Looking at the sensitivity of phytoplankton species in relation to the light spectrum is important, but no one has questioned how water currents affect toxin concentration in the microenvironment. Could current speed or turbulence increase the exposure time of phytoplankton to toxins and promote ROS formation? Don't these physical parameters accelerate metabolic responses?

The impact of stream flows is significant, but here the distribution of toxins at the microscale is also critical along with their concentration. Could the homogenizing effect of flow intensity be eliminating toxin concentration gradients? Is there potential for localized high concentrations to trigger an ROS response, or is species adaptation dependent on the existence of these fluctuations?

Localized high concentration can trigger ROS response, but shouldn't we consider the diffusion rate of toxins here? To what extent does the effect of temperature and viscosity on diffusion sustain these gradients? Is there any data on whether the flow rate affects the molecular movement of toxins or if it establishes a direct link to the ROS mechanism?

Temperature and viscosity indeed influence diffusion, but it is unknown whether there is any change in diffusion rates up to the denaturation temperature in cases where toxins are protein-based. In other words, how does ROS stimulation change within the limits of molecular stability? Particularly under temperature stress, could there be an adaptation mechanism that alters the toxin-peroxidation relationship in phytoplankton?

Molecular stability of toxins and the ROS mechanism are being discussed, but why are we skipping the carbonate buffer system? Could carbonate ions serve as a bridge between pH and redox potential? It seems especially that the acidification disrupting the carbonate equilibrium system could affect the duration that toxins remain in their active form. Has this been measured in relation to phytoplankton metabolism?

The carbonate buffer system is a valid point, but it is also important to consider how dependent biological systems are on these buffering mechanisms. Have the sensitivities of the enzymes involved in phytoplankton metabolism to changes in carbonate ion concentration been measured? Because pH variations in enzymatic activities can play a direct role in toxin production. Has any biochemical examination of this nature been conducted?

The sensitivity of enzymes to pH variations can be effective in terms of toxin production, but I think the effects of pH on ribosomal protein synthesis rates should also be considered here. In particular, could the slowing down of translation processes create an effect that limits the toxin production capacity of phytoplankton? Have these biochemical processes been measured in how they adapt to environmental fluctuations?

Translation processes are important, but it seems that the effect of mitochondrial respiration on ROS production is a bit overlooked here. How do changes in the energy metabolism of phytoplankton shape toxin production or adaptation mechanisms? For example, is there any data on the level at which mitochondrial activity remains under oxidative stress? Do these processes proceed in parallel with the biosynthesis of toxins?

Mitochondrial activity may parallel toxin biosynthesis, but the role of chloroplasts seems somewhat overlooked here. How does the relationship between ROS production in the photosynthetic electron transport chain and oxidative stress affect toxin synthesis? I believe the impact of sudden changes in light intensity on these processes should be investigated.

At the point of photosynthetic ROS production you mentioned, the sensitivity of pigments to photooxidation and energy transfer dynamics may also be critical. Specifically, is there an effect of this sensitivity on the capacity to adapt to changes in light intensity? Has the relationship between changes in toxin synthesis and pigment composition been examined?

The sensitivity of pigments to photo-oxidation is an important point, but one should also consider the different effects of light wavelengths along with light intensity. Has the potential for short wavelengths to create phot oxidative stress and its effect on toxin synthesis equilibrium been measured? Do we know the limits of pigment adaptations, especially regarding the role of UV radiation in ROS production?

When I think of UV radiation, this comes to mind: The effect of UV on the DNA repair mechanisms of phytoplankton has hardly been discussed. Could the capacity for toxin synthesis vary depending on the rate of DNA damage repair? After all, the overall stress response in cells can trigger the production of toxic metabolites.

DNA repair mechanisms may vary due to UV influence, but there is a key point here: the effect of indirect stress that UV creates on cellular redox balance. Redox imbalance might not only affect DNA damage but also cellular signaling pathways and toxin biosynthesis pathways. Has the direct effect of shifts in redox levels on toxin production rate been measured?

You mentioned redox imbalance, but the role of the glutathione system within the cell in this imbalance has not been discussed at all. Can glutathione depletion accelerate toxin biosynthesis? Especially under oxidative stress, could the inadequacy of cellular defense mechanisms act as a trigger for toxin production? Has the effect of variations in glutathione levels on toxin production been studied?

In addition to the glutathione system, the responses of the peroxiredoxin and thioredoxin systems to redox imbalance may also be significant in terms of toxin biosynthesis. In particular, have the capacity limits of these antioxidant systems and their connection to toxin production processes been measured under oxidative stress? It may also be critical to determine whether other redox regulators are activated in parallel to glutathione deficiency.

Peroxiredoxin and thioredoxin systems touch on an important point, but you might have overlooked the impact of lipid peroxidation in cellular membranes during these processes. Oxidative stress can increase lipid peroxidation, which can disrupt membrane structure and also trigger toxin biosynthesis with secondary reactive products. Has the role of membrane stability in toxin production processes been measured?

You mentioned the effect of lipid peroxidation on toxin biosynthesis, but it is unclear whether the ratios of unsaturated fatty acids in the membrane and their susceptibility to oxidation have been taken into account. Is there a connection between cells that carry more oxidizable lipids and their capacity for toxin production? Has the effect of these ratios on membrane fluidity and redox balance been measured?

The levels of unsaturated fatty acids are an important detail, you are right, but there is something striking here: lipid peroxidation products may not only modulate membrane structure but also indirectly affect toxin biosynthesis by modulating intracellular signaling pathways. Could these products exacerbate redox imbalance by further increasing ROS production? Additionally, could changes in membrane fluidity have a facilitating effect on toxin release?

This speech discussed the thioredoxin and peroxiredoxin systems, but their interactions with each other were not elaborated much. I wonder how the mechanisms by which these systems support or suppress each other play a role in the processes of toxin biosynthesis? Particularly, have deviations in toxin production been measured when one system becomes more active than the other?

If we are talking about the balance in the mechanisms of mutual support or suppression between the thioredoxin and peroxiredoxin systems, the regulatory role of NADPH could be critical here. The NADPH dependency of these systems might clarify how they respond to toxin biosynthesis under redox imbalance. Has the indirect effect of fluctuations in the NADPH pool on these processes been measured?

The NADPH dependency of the thioredoxin and peroxiredoxin systems is significant, but the diversity of NADPH production pathways and their effects on toxin biosynthesis should also be considered. In particular, have the roles of alternative NADPH sources outside the pentose phosphate pathway been sufficiently studied in this process? Not only the main pathway but also the effects of side pathways on redox balance can make a difference.

The diversity of NADPH production pathways has been discussed, but glutamine metabolism hasn't been addressed. Could glutamine have an indirect contribution to NADPH production via the malate-aspartate cycle? How are redox tolerance and toxin biosynthesis affected in glutamine-dependent cells in this context?

Speaking of the contribution to NADPH production through glutamine metabolism, it's important to note that the conversion of glutamine to glutamate via glutaminase, and its entry into the TCA cycle, as well as its addition to redox balance through α-ketoglutarate, are significant—not just the malate-aspartate cycle. How critical is the impact of glutamate on direct glutaminolytic flux in biosynthesis of toxins? In other words, it may be necessary to examine the role of α-ketoglutarate in the toxin production mechanism alongside NADPH more clearly.

If we are talking about glutamine metabolism and redox balance, we should not overlook the mitochondrial isocitrate dehydrogenase (IDH) enzyme here. In addition to the production of α-ketoglutarate, the role of IDH in generating NADPH may provide an additional control point for toxin biosynthesis, especially in glutamine-dependent cells. Has the effect of this enzyme activity on redox tolerance and specific toxin release been examined?

When we're talking about the role of IDH in NADPH production, it seems you've overlooked one point: It's known that the IDH1 and IDH2 isoforms function specifically in different cellular regions. Could the regional effects of these isoforms impact toxin biosynthesis processes in different ways? For example, is the role of cytosolic IDH1 in lipid synthesis and ROS management more prominent compared to mitochondrial IDH2?

The functional differences between IDH1 and IDH2 isoforms are an important point, but have you considered this: Could the activity of these isoforms be regulated differently under cellular stress conditions? Particularly in situations like hypoxia, the potential regulatory effect of HIF-1α on IDH isoforms could be a determining variable in toxin biosynthesis. Has there been any research on this?

The regulation of IDH isoforms by HIF-1α may play a critical role in hypoxic adaptation, but the substrate preferences of IDH should also be considered here. Particularly, the changes in the PDH and PDK1 axis via the consumption of α-ketoglutarate and the accumulation of succinate during hypoxia could provide a clearer idea of how IDH isoforms shape redox and carbon flow. Is there specific data on these mechanisms?

Well, while the regulation of HIF-1α and IDH isoforms is being discussed, how much is the effect of α-ketoglutarate accumulation related to succinate on epigenetic modifications during hypoxia being debated? Is there a decrease in the activity of α-ketoglutarate-dependent dioxygenase enzymes in this case? In other words, the effect on toxin biosynthesis may not be limited to isoform preferences.

When you talk about epigenetic modifications, it may be worth looking specifically at the effects of α-ketoglutarate on histone demethylases right now. Understanding how the accumulation of succinate and fumarate during hypoxia alters the local chromatin structure through the inhibition of these enzymes could be an important gap while mapping toxin biosynthesis. Have the effects of these processes on gene expression modulation been studied?

The inhibition of PHD enzymes through α-ketoglutarate deficiency and succinate accumulation in a hypoxic environment has been discussed, but there seems to be a missing point here: How much does this process affect the overall flow of the TCA cycle? Is there any data on the reduction of mitochondrial phosphorylation in hypoxic conditions and its effect on the NADPH production of IDH isoforms? This disruption in carbon flow could be critical, not so much for toxin biosynthesis, but for energy homeostasis.

If we are discussing the effect of IDH isoforms on NADPH production through energy homeostasis, we need to consider this: How does increased lactate production via glycolysis during hypoxia affect the redox balance in the cytosol? Could there be a mechanism whereby the accumulation of NADH indirectly suppresses IDH1 activity? I believe that the lactate/NADH balance represents a gap that should not be overlooked in toxin biosynthesis.

You mention that IDH1 activity can be suppressed via lactate/NADH balance, but there is an important question here: Could increased glutaminolysis alongside hypoxia provide an alternative carbon source for IDH1? Particularly, how crucial is the flexibility of IDH1 in this process in the context of glutathione synthesis and redox balance? Is there anything that clarifies this?

It is true that glutaminolysis can create an alternative carbon source for IDH1, but we need to look at the net effect of the conversion from glutamate to α-ketoglutarate here. How effective is the regulation of GDH in a hypoxic environment, or the contribution of the transamination pathway to the flow of α-ketoglutarate? Additionally, the indirect effect of glutaminolysis on mitochondrial IDH2 activity seems to have not been discussed. This connection could be an overlooked area in terms of energy balance and toxin biosynthesis.

So, while the flow of α-ketoglutarate via glutaminolysis is being discussed, how is the regulation of IDH1/2 shaped through mTOR activation? Has the effect of glutamine-dependent carbon flow on mTORC1 activity, along with hypoxia, and consequently the contribution of IDH to energy metabolism been examined in more detail? This perspective could also be critical not just for toxins but for general cellular adaptation.

The connection between glutaminolysis and mTORC1 has been discussed, but it seems that the effect of hypoxia-induced ROS production on IDH1/2 activities is being overlooked. How much does NADPH production from glutaminolysis buffer this oxidative stress? Additionally, could IDH2's mitochondrial location play a more critical role in ROS regulation?

If we are going through the connection between ROS and IDH2, the critical question here is: Does the increased ROS in a hypoxic environment have a specific effect on the allosteric regulation of IDH2? Because the insufficiency of NADPH buffering capacity may increase the oxidation sensitivity of IDH2. Is there any data regarding whether ROS modifications alter the kinetic parameters of the enzyme?

If we are discussing the possible allosteric effects of ROS on IDH2 in a hypoxic environment, it is also necessary to consider the following: In this process, could ROS not only be limited to the oxidation of IDH2 but also affect the mitochondrial membrane potential, thereby altering the overall rate of the TCA cycle? In other words, beyond the kinetic parameters of IDH2, it might be worth questioning the global potential impact on the cycle. Has such a cross-effect mechanism been studied?

If we are discussing the effect of ROS on mitochondrial membrane potential in relation to the rate of the TCA cycle, it is also important to add this: In the long-term effects of hypoxia, the increased activation of PDH kinase through HIF-1α may suppress the cycle at the outset by limiting the input of acetyl-CoA. In this case, could the redistribution of substrates fueling the cycle potentially become more critical than the kinetics of IDH2? Particularly, how directed the flow of pyruvate from glycolysis is seems to be a significant open question here.

You say that the TCA cycle is suppressed through HIF-1α and PDH kinase activation, but can’t you have missed this point? How effective are the feedback mechanisms of ROS production via SDH from succinate in conjunction with hypoxia? It seems like the impact of this slowdown in cycle rate on complex II's production of FADH2 from succinate has not been discussed. Could this create a chain that extends all the way to IDH2 via NADPH?

Here, the relationship between SDH's production of FADH2 from succinate and ROS has been addressed, but the following is missing: the effect of TCA cycle intermediates like fumarate and succinate on HIF stabilization and the indirect regulation of gene expression in a hypoxic environment. How does the accumulation of these metabolites affect IDH1/2 activities through NADPH-dependent redox balance? In other words, the issue is not limited to ROS production; we also need to consider the downstream effects of these accumulations.

But we also need to question this here: While the production of ROS via succinate/FADH2 through complex II is discussed in a hypoxic environment, what is the contribution of succinate accumulation through pathways independent of succinate dehydrogenase (SDH)? In other words, in the case of SDH inhibition, could the effect of succinate on HIF-1α stabilization through alternative pathways create a ROS mechanism completely disconnected from the TCA cycle? I think this is a missing link.

There is discussion about succinate accumulation and HIF-1α stabilization under hypoxic conditions, but the specific export of succinate outside the mitochondria independent of SDH inhibition and how this exported succinate activates extracellular receptors (e.g. SUCNR1) to trigger additional signaling pathways has not been discussed. Could such a paracrine/autocrine effect chain create an indirect feedback on IDH2 activities? For example, how do these external signals shape the global metabolic adaptation of the cycle?

This discusses the possibility of creating an indirect effect chain on IDH2 through SUCNR1 activation and paracrine effects, but we are overlooking one point: how long can the mechanism that transports the accumulation of succinate out of mitochondrial metabolism be sustained due to SDH inhibition? Don't the capacities of succinate/succinate transporter proteins define the limits of this adaptation? Has the potential for excess succinate to create an auto-intoxicating effect never been considered?

But viewing succinate accumulation merely as a continuous adaptation might be misleading, as other intramitochondrial mechanisms could also be at play, similar to the export of succinate outside the mitochondria. For instance, how does the inhibitory effect of succinate on α-KG dependent enzymes disrupt this cycle? In other words, shouldn't we consider a broader regulatory role in terms of intracellular redox balance, rather than solely focusing on SUCNR1 or transport capacities?

Everyone is focusing on the accumulation of succinate and carrier capacities, but one must ask: Has it been studied whether succinate that is transported outside the mitochondria, rather than succinate accumulating within the mitochondria, affects other redox buffers directly aside from ROS production? For example, how determinative is the effect of succinate accumulation on the GSH/GSSG ratio? This might also be inhibiting IDH2 from a different perspective.

Let me add one more point: What's the situation regarding the effect of succinate accumulation in the mitochondria not only on ROS production but also on the dynamics of fumarate hydrolysis? Could a change in the activity of the fumarase enzyme also affect other intermediates in the cycle? Perhaps the possibility that succinate accumulation may disrupt the fumarate/succinate balance and trigger different chain reactions is being overlooked.

So, whether the accumulation of succinate is localized within the mitochondria or transported, is the effect of prolonged exposure to SDH inhibition on NADH/NAD+ ratios taken into account directly? This is important because this ratio can trigger general redox balance throughout the cycle as well as ROS production mechanisms independent of the complex. In other words, reducing the issue to just succinate may be overly simplistic.

As I was reading this, I thought about something: We're talking about the accumulation of succinate due to SDH inhibition, but the possibility that there could be a change in the substrate specificity of SDH itself has not been discussed at all. For example, could a different metabolite competitively inhibit SDH? If so, this could directly create a ROS mechanism independent of succinate levels and make the cycle more complex. Has this been tested?

The possibility of a change in SDH's substrate specificity is interesting, but one must ask: Is this change really due to competitive inhibition, or is another mechanism, such as post-translational modifications affecting the binding kinetics to SDH, coming into play? If modifications are involved, could this process position succinate accumulation as a secondary result?

We are talking about the change in the substrate specificity of SDH, but how much data is available specifically on which post-translational modifications are involved? Which processes, such as phosphorylation, acetylation, or ubiquitination, are more dominant here? Has it ever been tested whether these modifications create tissue-specific differences? Because redox balance and metabolic responses can vary significantly on a tissue basis.

The change in the substrate specificity of SDH or post-translational modifications is being discussed, but the real question here might be: Has it been experimentally shown that the accumulation of succinate creates a reversible feedback loop on SDH activity? In other words, is this loop a dynamic equilibrium or more of a pathological deviation dependent on accumulation?

Experimental data indicating that succinate accumulation provides feedback to SDH activity is important, but if we think of this as a dynamic balance, how energy dependent is this feedback? Because if ATP levels are decreasing, the long-term sustainability of this type of cycle may be questionable. Additionally, has the effect of the ATP/ADP ratio on this mechanism been tested?

For example, we talked about post-translational modifications, but has it been thoroughly examined which specific amino acid regions of SDH are modified and how this affects the enzyme's kinetic parameters? Does the modification that reduces activity alter the surface, or does it interfere with the active site? This distinction seems critical in understanding which mechanism is predominant.

Well, why isn't there any discussion about whether there are differences between the isoforms of SDH while going into such detail about modifications and kinetic parameters? If the sensitivity levels of SDH isoforms to modification vary across different tissues, the results could change completely. Has a comparison been made on this topic?

It's important to discuss the differences among the isoforms of SDH, but I think the main point that often gets overlooked is the impact these isoform differences have on mitochondrial localization and membrane binding dynamics. The conformation of the active site can create different binding kinetics in specific isoforms. Has the effect of these binding kinetics on succinate accumulation or ROS production been investigated?

While discussing the relationship between the isoform differences of SDH and mitochondrial localization, one should also question: Does this localization only affect binding kinetics, or does it play a role in creating a specific metabolic microenvironment within the organelle? Because the regional redox states within the mitochondria may lead to different binding models of the same isoform. Are there any studies conducted on these effects?

If we are talking about the regional redox states within mitochondria, shouldn't we also examine the potential relationship between ROS production and succinate dehydrogenase? In other words, is SDH a catalyst in ROS production or is it rather a byproduct of a side effect mechanism? It seems difficult to fully understand the microenvironment and isoform effects without making this distinction.

You're saying it's hard to understand the microenvironment and isoform effect, but there's something else that needs to be asked here: Have the binding kinetics of SDH been tested directly for their effect on lipid peroxidation or mitochondrial membrane fluidity, aside from the redox state? Because interpreting the redox balance of an organelle with disrupted membrane dynamics purely through the isoform would be incomplete. Has this connection been studied?

But while we are discussing binding kinetics, isoforms, and redox balance in detail, why aren’t we talking about this: Do the specific isoforms of SDH trigger other signaling pathways through the accumulation of different metabolites (for example, fumarate or malonate) besides ROS? Wouldn’t the mitochondrial microenvironment or membrane dynamics be poorly analyzed without understanding how these by-products affect different mechanisms throughout the cell? Is there any data on this?

But there's something missing here: we're discussing the different mechanisms triggered by SDH, but how much has the connection to cellular energy sensors been addressed? For instance, how are pathways like AMPK or mTOR affected by these changes? Is there a connection? I think this part is critical.

The connections between AMPK and mTOR are critical, but it should be added: Is there anything on how the modifications of SDH affect energy sensors in specific cell types? For instance, the same modification in muscle cells and hepatocytes could create different AMPK/mTOR responses. How pronounced is this difference in biological signaling?

It should be noted that while discussing the effects of SDH modifications on both energy sensors and cellular stress responses, the interaction with cell cycle regulators seems to be overlooked. Is there any research on how ROS accumulation through p21 or CDK inhibitors initiates signaling independently of cellular energy balance? Beyond AMPK/mTOR, the direct effects on cell cycle control might also be significant.

When discussing the effects of SDH through cell cycle regulators, shouldn't we add: Especially in signaling pathways due to ROS accumulation, do DNA damage response mechanisms (e.g., ATM/ATR) become activated? Or do these response mechanisms directly interact with cell cycle regulation? Because trying to draw a broader framework beyond AMPK/mTOR could be incomplete without understanding the entirety of this chain.

When discussing the potential effects of SDH on DNA damage response mechanisms, the role of mitochondrial matrix proteins such as ATAD3A should not be overlooked. In order to elucidate the relationship between mitochondrial dynamics and DNA damage, it is essential to consider not only the redox system but also these types of regulatory factors within organelle integrity. Is there an interaction between ATAD3A and SDH activity?

The potential interaction of ATAD3A with SDH activity has been questioned, but we haven't discussed a specific mechanism here: how closely is ATAD3A's role in replicating and organizing mitochondrial DNA related to ROS accumulation and its impact on signaling pathways? Could SDH modulation now directly affect the functions of ATAD3A? Specifically, has the effect of changes in SDH activity on mitochondrial genome stability been studied?

We are discussing the interaction of SDH-ATAD3A, but what is missing is: Is ATAD3A's role in mitochondrial DNA organization shaped solely by SDH modifications, or is it part of a broader protein-protein network? For example, could mitochondrial fusion/fission dynamics (like MFN1/2, OPA1) be involved in this process? How does SDH's activity intersect with these dynamics?

While discussing the intersection of ATAD3A and SDH interactions with mitochondrial fusion/fission dynamics, one thing is being overlooked: Where does lipid metabolism come into play in this process? Specifically, have the contributions of mitochondrial-specific lipids, such as cardiolipin, to membrane dynamics and their potential impact from SDH modifications been examined? Shouldn't we also approach both organelle integrity and redox balance from a lipid perspective?

Looking from the perspective of cardiolipin, we need to ask the following: Is there any research on how SDH modifications shape lipid-protein interactions? In particular, could possible changes in SDH's binding affinity for cardiolipin affect mitochondrial membrane potential and the stability of protein complexes? It seems there is a gap in this regard.

You mentioned there's a gap regarding the cardiolipin binding affinity of SDH, but we are not discussing phospholipid asymmetry here. So, have you considered the behavior of SDH in lipid raft regions? Has there ever been an investigation into the effect on Complex II's microdomain dependency? Does this operate in a more specific place within mitochondrial membrane organization?

Isn't it interesting to clarify the specific factors affecting membrane organization regarding the lipid raft behavior and microdomain dependency of SDH? For example, how exactly do the roles of SDH outside of oxidative phosphorylation impact the organization of phospholipid rafts? Do you have any studies related to protein-protein interactions within lipid rafts?

When discussing the behavior of SDH in lipid rafts, one must ask the following: Is there a specific isoform difference of SDH on these structures? For example, have the functional roles of SDHA and SDHB subunits in terms of raft dependency been examined? This distinction could clarify the mechanistic discussion.

Have you thought about how the binding of SDHA and SDHB isoforms to lipid rafts affects raft-dependent protein trafficking? For example, is the contribution of lipid rafts to SDH stability more pronounced, or is there evidence that SDH plays an active role in raft formation? It seems like a bidirectional process.

When discussing the lipid raft dependence of SDHA/SDHB isoforms, one aspect often overlooked is how the diversity and saturation levels of lipids in raft regions affect the binding kinetics and functional optimization of these subunits. For instance, is there any data on the displacement rates or binding continuity of the SDH subunits in raft regions that are richer in cholesterol content? This could be critical for understanding whether raft dynamics regulate SDH functionality in a bidirectional manner.

When discussing the displacement rates of SDH subunits in lipid-rich raft regions in terms of cholesterol content, shouldn't we take into account the membrane fluidity that varies according to the physical structure of the lipid rafts? To what extent do the differences between binding continuity in more rigid regions and kinetic behavior in more fluid areas affect functional optimization? In this context, it seems necessary to evaluate raft dependence not only based on lipid type but also on mechanical properties.

When discussing the cholesterol content and membrane fluidity, I believe the impact of protein-lipid compatibility in the raft regions on energy dynamics should also be considered. Specifically, has it been tested whether the binding energy of SDH in the rafts positively contributes to the steps of oxidative phosphorylation? Thermodynamic optimization can be as decisive in the process as mechanical properties.

Well, if we approach it through thermodynamic optimization, has there been a comparison of the binding energy of SDH to lipid rafts with the binding energy in regions outside the rafts? How much do the mechanical and thermodynamic differences of the rafts interfere with the binding continuity of SDH? Also, is there anything related to the reflection of these processes on the overall mitochondrial function?

When discussing cholesterol content and membrane fluidity, is there any data indicating under what conditions SDH is drawn more towards the rafts compared to the lipid composition in the direct non-raft regions? For instance, could lower cholesterol-saturated lipid ratios outside of raft regions create a sort of "pull" effect in the binding kinetics of SDH? This could explain why the mechanical and thermodynamic advantages of rafts are concentrated in certain areas.

In addition to the question regarding the lipid composition of raft-excluded regions, it is necessary to ask the following: If it is assumed that SDH tends to be recruited to rafts in different compositional domains, does this recruitment stem from raft protein-protein interactions, or is it simply a binding specific to the lipid environment? Is there any data examining whether regulatory proteins such as caveolin or flotillin in raft regions establish a direct interaction with SDH? The function of these proteins could shift the mechanism in a different direction.

I agree with the hypothesis that low cholesterol-saturated lipid ratios in regions outside lipid rafts pull SDH (succinate dehydrogenase) towards the rafts, but I believe this is not solely limited to a "pulling" effect. Has it been tested whether the energy difference between the lipid flexibility in raft-external regions and the rigid structure inside the rafts creates a gradient affecting binding affinity? We should consider the possibility that SDH binding to rafts might actually be a result of a mechanical adaptation.

It's interesting that low cholesterol-saturated lipid ratios in non-raft regions create an energy gradient, but I wondered: Does the binding kinetics of SDH have to rely entirely on lipid diversity? How has the possibility of other regulatory factors, aside from raft proteins like flotillin/caveolin (such as kinases), being involved in this process been evaluated? I think there could be effects of protein-protein interactions that transcend lipid dependence.

When discussing the binding kinetics of SDH to lipid rafts, has it been examined whether this binding correlates with cellular stress responses? Specifically, is there data on whether compositional changes of lipid rafts during conditions such as hypoxia or oxidative stress create an adaptation mechanism affecting the binding continuity of SDH? This could demonstrate the relationship between binding and systemic responses.

The kinetics of SDH (succinate dehydrogenase) binding to raft regions are influenced by conditions such as hypoxia or oxidative stress, which are significant. However, I wonder: is it only the lipid composition that affects binding continuity, or could more physical parameters, such as the overall tension state of the mitochondrial membrane, also play a role? Is there any data indicating that such tension outside the raft region suppresses SDH dynamics?